From: EPB41L4A-AS1 and UNC5B-AS1 have diagnostic and prognostic significance in osteosarcoma
Parameter | N | Low EPB41L4A-AS1 (n = 52) | High EPB41L4A-AS1 (n = 61) | P | Low UNC5B-AS1 (n = 49) | High UNC5B-AS1 (n = 64) | P |
---|---|---|---|---|---|---|---|
Age (years) | 0.840 | 0.062 | |||||
< 18 | 62 | 28 | 34 | 22 | 40 | ||
≥ 18 | 51 | 24 | 27 | 27 | 24 | ||
Gender | 0.245 | 0.555 | |||||
Male | 52 | 27 | 35 | 21 | 31 | ||
Female | 61 | 25 | 36 | 28 | 33 | ||
Tumor site | 0.345 | 0.964 | |||||
Femur | 51 | 22 | 29 | 22 | 29 | ||
Tibia | 23 | 8 | 15 | 11 | 12 | ||
Humeral bone | 12 | 6 | 6 | 5 | 7 | ||
other | 27 | 16 | 11 | 11 | 16 | ||
SSS stage | 0.048* | 0.013* | |||||
I–II | 81 | 42 | 39 | 41 | 40 | ||
III | 32 | 10 | 22 | 8 | 24 | ||
LDH | 0.749 | 0.051 | |||||
< 850 IU/L | 67 | 30 | 37 | 24 | 43 | ||
≥ 850 IU/L | 46 | 22 | 24 | 25 | 21 | ||
ALP | 0.695 | 0.699 | |||||
< 280 IU/L | 76 | 34 | 42 | 32 | 44 | ||
≥ 280 IU/L | 37 | 18 | 19 | 17 | 20 |